Pacin, a novel bacteriocin from Pseudomonas strain 166, exhibits anti-MRSA activity with low toxicity and high therapeutic potential
{{output}}
The emergence and rapid spread of methicillin-resistant Staphylococcus aureus (MRSA) pose a significant threat to public health, underscoring the urgent need for the development of effective antibacterial agents. Bacteriocins, as highly promising antibacterial... ...
